Saraswat A - Search Results

1

Correction: Patel et al. Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers 2023, 15, 182.

Patel A, Saraswat A, Patel H, Chen ZS, Patel K. Patel A, et al. Among authors: saraswat a. Cancers (Basel). 2024 Dec 27;17(1):44. doi: 10.3390/cancers17010044. Cancers (Basel). 2024. PMID: 39796788 Free PMC article.

2

Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer.

Patel A, Saraswat A, Patel H, Chen ZS, Patel K. Patel A, et al. Among authors: saraswat a. Cancers (Basel). 2022 Dec 28;15(1):182. doi: 10.3390/cancers15010182. Cancers (Basel). 2022. PMID: 36612178 Free PMC article.

3

In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells.

Patki M, Saraswat A, Bhutkar S, Dukhande V, Patel K. Patki M, et al. Among authors: saraswat a. Exp Cell Res. 2021 Aug 15;405(2):112660. doi: 10.1016/j.yexcr.2021.112660. Epub 2021 May 25. Exp Cell Res. 2021. PMID: 34048785

4

Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy.

Saraswat A, Vemana HP, Dukhande VV, Patel K. Saraswat A, et al. Heliyon. 2022 Jan 3;8(1):e08702. doi: 10.1016/j.heliyon.2021.e08702. eCollection 2022 Jan. Heliyon. 2022. PMID: 35036599 Free PMC article.

5

Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera.

Vartak R, Saraswat A, Yang Y, Chen ZS, Patel K. Vartak R, et al. Among authors: saraswat a. Pharm Res. 2022 Nov;39(11):2745-2759. doi: 10.1007/s11095-022-03184-3. Epub 2022 Feb 10. Pharm Res. 2022. PMID: 35146591

6

Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs).

Saraswat AL, Vartak R, Hegazy R, Patel A, Patel K. Saraswat AL, et al. Drug Discov Today. 2023 Jan;28(1):103387. doi: 10.1016/j.drudis.2022.103387. Epub 2022 Sep 29. Drug Discov Today. 2023. PMID: 36184017 Review.

7

In Vitro Assessment of Cisplatin/Hyaluronan Complex for Loco-Regional Chemotherapy.

Banella S, Saraswat A, Patel A, Serajuddin ATM, Colombo P, Patel K, Colombo G. Banella S, et al. Among authors: saraswat a. Int J Mol Sci. 2023 Oct 29;24(21):15725. doi: 10.3390/ijms242115725. Int J Mol Sci. 2023. PMID: 37958708 Free PMC article.

8

Delineating effect of headgroup and preparation method on transfection versus toxicity of DNA-loaded lipid nanocarriers.

Saraswat A, Patel K. Saraswat A, et al. Nanomedicine (Lond). 2023 Nov;18(26):1921-1940. doi: 10.2217/nnm-2023-0219. Epub 2023 Dec 11. Nanomedicine (Lond). 2023. PMID: 38078422

9

Development and in-depth characterization of BRAFi-resistant melanoma cell lines in vitro and in vivo.

Saraswat A, Patel K. Saraswat A, et al. Exp Cell Res. 2024 May 1;438(1):114033. doi: 10.1016/j.yexcr.2024.114033. Epub 2024 Apr 7. Exp Cell Res. 2024. PMID: 38593916

10

Nanoformulation of PROteolysis TArgeting Chimera targeting 'undruggable' c-Myc for the treatment of pancreatic cancer.

Saraswat A, Patki M, Fu Y, Barot S, Dukhande VV, Patel K. Saraswat A, et al. Nanomedicine (Lond). 2020 Aug;15(18):1761-1777. doi: 10.2217/nnm-2020-0156. Epub 2020 Jul 23. Nanomedicine (Lond). 2020. PMID: 32698663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters